Skip to content

Insider · CIK 0001288232

FAVORITO TAMARA A

Reports to the SEC for 5 companies · SOLANA BEACH, CA

Transactions

50

Companies

5

Filings

10

CIK

0001288232

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2026-07-17ARTLARTELO BIOSCIENCES, INC. · Stock Option (right to buy)A Award—
2026-06-04ZVRAZEVRA THERAPEUTICS, INC. · Stock Option (right to buy)A Award—
2026-01-30ARTLARTELO BIOSCIENCES, INC. · Stock Options (right to buy)A Award—
2025-10-28ARTLARTELO BIOSCIENCES, INC. · Warrant (right to buy)C Conversion—
2025-10-28ARTLARTELO BIOSCIENCES, INC. · Warrant (right to buy)C Conversion—
2025-10-28ARTLARTELO BIOSCIENCES, INC. · Convertible Promissory NoteC Conversion—
2025-10-28ARTLARTELO BIOSCIENCES, INC. · Convertible Promissory NoteC Conversion—
2025-09-12ZVRAZEVRA THERAPEUTICS, INC.P Purchase+$24.7K
2025-05-29ZVRAZEVRA THERAPEUTICS, INC. · Stock Option (right to buy)A Award—
2025-05-01ARTLARTELO BIOSCIENCES, INC. · Convertible Promissory NoteP Purchase—
2024-12-20ARTLARTELO BIOSCIENCES, INC. · Stock Option (right to buy)A Award—
2024-05-13ZVRAZEVRA THERAPEUTICS, INC. · Stock Option (right to buy)A Award—
2024-02-28ARTLARTELO BIOSCIENCES, INC. · Stock Option (right to buy)D Disposition to Issuer—
2024-02-28ARTLARTELO BIOSCIENCES, INC. · Stock Option (right to buy)D Disposition to Issuer—
2024-02-28ARTLARTELO BIOSCIENCES, INC. · Stock Option (right to buy)D Disposition to Issuer—
2024-02-28ARTLARTELO BIOSCIENCES, INC. · Stock Option (right to buy)A Award—
2024-02-28ARTLARTELO BIOSCIENCES, INC. · Stock Option (right to buy)A Award—
2024-02-28ARTLARTELO BIOSCIENCES, INC. · Stock Option (right to buy)A Award—
2024-02-28ARTLARTELO BIOSCIENCES, INC. · Stock Option (right to buy)A Award—
2024-02-28ARTLARTELO BIOSCIENCES, INC. · Stock Option (right to buy)A Award—
2024-02-28ARTLARTELO BIOSCIENCES, INC. · Stock Option (right to buy)D Disposition to Issuer—
2024-02-28ARTLARTELO BIOSCIENCES, INC. · Stock Option (right to buy)D Disposition to Issuer—
2023-08-30HURATuHURA Biosciences, Inc./NV · Options (Right to Buy)A Award—
2023-08-04ARTLARTELO BIOSCIENCES, INC. · Stock Option (right to buy)A Award—
2023-06-30ARTLARTELO BIOSCIENCES, INC. · Stock Option (right to buy)A Award—
2023-05-31ZVRAZEVRA THERAPEUTICS, INC. · Stock Option (right to buy)A Award—
2023-04-25ZVRAZEVRA THERAPEUTICS, INC. · Stock Option (right to buy)A Award—
2023-03-17ZVRAZEVRA THERAPEUTICS, INC.P Purchase+$2,502.359
2022-07-01HURATuHURA Biosciences, Inc./NV · Options (Right to Buy)A Award—
2022-06-28ZVRAZEVRA THERAPEUTICS, INC. · Stock Option (right to buy)A Award—
2022-06-24ARTLARTELO BIOSCIENCES, INC. · Stock Option (right to buy)A Award—
2022-05-20ZVRAZEVRA THERAPEUTICS, INC.P Purchase+$974
2021-09-22HURATuHURA Biosciences, Inc./NV · Options (Right to Buy)A Award—
2021-07-16ARTLARTELO BIOSCIENCES, INC. · Stock Option (right to buy)A Award—
2021-04-29HURATuHURA Biosciences, Inc./NV · Options (Right to Grant)A Award—
2021-03-05ARTLARTELO BIOSCIENCES, INC. · Stock Option (right to buy)A Award—
2016-10-31VRDNViridian Therapeutics, Inc.\DE · Restricted Stock UnitsM Exercise/Conversion—
2016-10-31VRDNViridian Therapeutics, Inc.\DE · Restricted Stock UnitsM Exercise/Conversion—
2016-10-31VRDNViridian Therapeutics, Inc.\DEF Tax Payment−$16.4K
2016-10-31VRDNViridian Therapeutics, Inc.\DEM Exercise/Conversion—
2016-10-31VRDNViridian Therapeutics, Inc.\DEF Tax Payment−$7,548.12
2016-10-31VRDNViridian Therapeutics, Inc.\DEM Exercise/Conversion—
2016-08-08VRDNViridian Therapeutics, Inc.\DEF Tax Payment−$5,084.74
2016-08-08VRDNViridian Therapeutics, Inc.\DEM Exercise/Conversion—
2016-08-08VRDNViridian Therapeutics, Inc.\DE · Restricted Stock UnitsM Exercise/Conversion—
2016-03-28VRDNViridian Therapeutics, Inc.\DE · Restricted Stock UnitsA Award—
2015-08-12VRDNViridian Therapeutics, Inc.\DE · Employee Stock Option (Right to Buy)A Award—
2015-08-04VRDNViridian Therapeutics, Inc.\DEM Exercise/Conversion—
2015-08-04VRDNViridian Therapeutics, Inc.\DEF Tax Payment−$13.3K
2015-08-04VRDNViridian Therapeutics, Inc.\DE · Restricted Stock UnitsM Exercise/Conversion—

Recent filings

10